Implantable technology for the treatment of high blood pressure

Startup

ABOUT CVRX

      
CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure.

CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™  is designed to trigger the body’s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology.

Barostim neo is CE marked in Europe for the treatment of hypertension patients.   It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.
    
Organization founded in United States.

SECTORS - INDUSTRY

LOCATIONS

PROFILE STRENGTH

This profile looks great, do you want to share it with the world?
BEGINNER
ADVANCED
REAL PRO

NEWS

Recently added news from CVRx:
CVRx funding investment of 113M$

This website uses cookies to allow us to see how the site is used. If you continue to use this site we will assume that you are happy with this. If you want to use the site without cookies or would like to know more, you can do that. here .